Basal Cell Carcinoma (BCC) Clinical Trial
Official title:
Intralesional Cryosurgery for the Treatment of Basal Cell Carcinoma of the Lower Extremities in the Elderly - a Feasibility Study
A feasibility study for the treatment of Basal Cell Carcinoma of the lower extremities in
the elderly utilizing intralesional cryosurgery.
10 cases of BCC (confirmed by biopsy) in the lower extremity of elderly will undergo
intralesional cryotherapy. A Cryoneedle is introduced through the skin lesion (BCC) and thus
the BCC is frozen. Treatment success will be determined according to biopsy results 3 months
after treatment
BCC is the most common skin cancer. Many treatment modalities are acceptable including
cryotherapy - freezing of the skin lesion with liquid nitrogen. This method is highly
effective for the treatment of BCC. The purpose of this study is to determine the cure rates
of BCC utilizing intralesional cryotherapy.
surgery in the gold standard for the treatment of BCC, however in the case of skin
malignancy in the elderly and in the lower extremity, surgical complication (including skin
grafting) are high. Therefore cryotherapy which is a non surgical treatment method provides
an optimal therapeutic choice.
10 cases of BCC (confirmed by biopsy) in the lower extremity of elderly will undergo
intralesional cryotherapy. A Cryoneedle is introduced through the skin lesion and the BCC is
frozen. Treatment success will be determined according to biopsy results 3 months after
treatment. Participants will be followed at the out patient clinic for the duration of wound
healing, an expected average duration of 3 weeks.
;
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT02750033 -
Intraoperative Margin Assessment During Mohs Surgery
|
||
| Completed |
NCT00670189 -
A Phase 1 Study of BMS-833923 (XL139) in Subjects With Advanced or Metastatic Cancer
|
Phase 1 | |
| Completed |
NCT02144077 -
Safety and Efficacy Study for the Treatment of Non-Aggressive Basal Cell Carcinoma With Photodynamic Therapy
|
Phase 3 | |
| Completed |
NCT01108094 -
Pilot Biomarker Trial to Evaluate the Efficacy of Itraconazole in Patients w/ Basal Cell Carcinomas
|
Phase 2 |